Public Profile

Tianjin Pharma

Tianjin Pharma, officially known as Tianjin Pharmaceutical Group Co., Ltd., is a prominent player in the pharmaceutical industry, headquartered in Tianjin, China. Established in 1995, the company has made significant strides in the development and manufacturing of a diverse range of pharmaceutical products, including generic drugs, active pharmaceutical ingredients (APIs), and innovative therapies. With a strong presence in both domestic and international markets, Tianjin Pharma is recognised for its commitment to quality and innovation. The company’s core offerings are distinguished by their adherence to stringent regulatory standards and advanced production techniques. Notable achievements include various certifications and partnerships that enhance its market position, making Tianjin Pharma a trusted name in healthcare solutions.

DitchCarbon Score

How does Tianjin Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Tianjin Pharma's score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.

26%

Tianjin Pharma's reported carbon emissions

Tianjin Pharma, headquartered in CN, currently does not have publicly available data on its carbon emissions, including specific figures for Scope 1, 2, or 3 emissions. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of information suggests that the company may still be in the early stages of formalising its climate commitments or reporting practices. As the pharmaceutical industry increasingly prioritises sustainability, Tianjin Pharma's future actions in addressing carbon emissions will be crucial for aligning with global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Tianjin Pharma's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Tianjin Pharma is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Tianjin Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

CDP

Cambridge Healthcare Research

GB
Health Services
Updated 11 days ago

Alpha Analytical

US
Health Services
Updated 3 days ago

Siemens S.A.

UY
Health Services
Updated 3 days ago

Bioseutica

NL
Health Services
Updated 7 days ago

Holden Knight Healthcare Temp Ltd

GB
Health Services
Updated 11 days ago

Massy Distribution Limited

JM
Health Services
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers